New Born Screening Market – Size, Outlook, Trends and Forecast (2024 – 2032)

Newborn screening is a health program for screening new born’s right after birth to identify problems that affect child’s health in future. Newborn screening contains series of test which helps to detect the diseases and diagnosis are preventing disability and deaths.

Newborn Screening Market share:

Young Screening market is segmented by test type, product, technology, and geography. On basics of test type, the most substantial percentage is in North America because of the effort to reduce the disabilities of children, and genetic disorders for long-term.

Newborn Screening Market size:

Newborn Screening Market is accounted for USD XX billion in 2017 and expected to grow at a CAGR of X% to reach USD XX billion by 2024.

North America has the highest market for newborn screening market because of the developed infrastructure; the effort made to reduce disabilities; reimbursement policies are raising the demand for the market. During the forecast period, Asia-Pacific is going to have the quick growth in the market.

Newborn Screening Market growth:

The market for newborn screening is driven by factors such as an increase in some newborn diseases, technological development in healthcare, and incidences of critical congenital heart defects in newborns increasing the growth of newborn screening market.

Newborn Screening Market Industrial Analysis:

Newborn Screening Market is segmented by test type, product, technology, and geography. In this categorisation, the growth of the market is driven by test type segment classified by hearing screening test, dry blood spot test, and critical congenital heart disease test is the fastest growing market in the developed and developing countries.

Newborn Screening Market Outlook:

Newborn Screening is primarily used on infants right after their birth to detect the congenital disorders, which turns into mental retardation, dysfunctioning of organs, for instance, in healthcare and growing critical congenital heart defects have further increased the demand for newborn screening and its predominant in North America especially the US.

Newborn Screening Market Trends:

Agilent Technologies Inc. has acquired Oxfordshire, U.K.-based Cobalt Light Systems in July 2017.

PerkinElmer, Inc. agreed to acquire Euroimmun Medical Laboratory Diagnostics AG., in June 2017.

Newborn Screening Market Research Report Includes:

• An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
• To have complete market analysis through industry value chain analysis, Porter’s five, PESTLE, SWOT analysis, and Y-o-Y analysis.
• Regional and global diversity is analysed with the major countries and the unions.
• Scrutinizing the revenue generation on Year–On–Year
• Identifying DROC in the current market and their impact in altering the market dynamics.
• Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
• Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
• Identify the latest developments, market shares and strategies that are employed by the major market players, such as:
• PerkinElmer Inc.
• Trivitron Healthcare
• Masimo Corporation
• AB Sciex LLC
• Neogen Labs Pvt. Ltd.